Literature DB >> 17436204

Adherence to a home-based exercise program and incidence of cardiovascular disease in type 2 diabetes patients.

S Shinji1, M Shigeru, U Ryusei, M Mitsuru, K Shigehiro.   

Abstract

The aim of this study was to examine the association between adherence to a home-based exercise program and the incidence of cardiovascular disease (CVD) in patients with type 2 diabetes. We investigated 102 patients with type 2 diabetes aged 35 to 75 years, and followed them prospectively for 17.2 months. Before enrollment, all patients received a traditional exercise prescription. The exercise program consisted of a daily walking exercise at home for 20 - 30 minutes. Self-reported adherence to the exercise program and the incidence of CVD were confirmed by information obtained from telephone interviews. There were 38 dropouts among the patients in the exercise program. Dropouts were significantly younger than completers. The rate of obesity was significantly higher among the dropouts than among the completers. No differences were observed between the two groups for gender, history of CVD and other clinical characteristics. During the follow-up, we documented 8 new cases of CVD. The incidence of CVD during the follow-up was 1.56 percent among the program completers and 18.4 percent among the dropouts. Adherence to the home-based exercise was inversely related to the incidence of CVD (p < 0.01). These associations persisted after adjustment for age and other covariates. In conclusion, adherence to an exercise program is associated with a reduced incidence of CVD among patients with type 2 diabetes.

Entities:  

Mesh:

Year:  2007        PMID: 17436204     DOI: 10.1055/s-2007-964967

Source DB:  PubMed          Journal:  Int J Sports Med        ISSN: 0172-4622            Impact factor:   3.118


  7 in total

1.  Predictors of exercise intervention dropout in sedentary individuals with type 2 diabetes.

Authors:  Soohyun Nam; Devon A Dobrosielski; Kerry J Stewart
Journal:  J Cardiopulm Rehabil Prev       Date:  2012 Nov-Dec       Impact factor: 2.081

Review 2.  Using virtual reality to improve walking post-stroke: translation to individuals with diabetes.

Authors:  Judith E Deutsch
Journal:  J Diabetes Sci Technol       Date:  2011-03-01

3.  Mobile Exergaming for Health-Effects of a serious game application for smartphones on physical activity and exercise adherence in type 2 diabetes mellitus-study protocol for a randomized controlled trial.

Authors:  Christoph Höchsmann; Steffen P Walz; Juliane Schäfer; Jussi Holopainen; Henner Hanssen; Arno Schmidt-Trucksäss
Journal:  Trials       Date:  2017-03-06       Impact factor: 2.279

Review 4.  Exercise as A Potential Therapeutic Target for Diabetic Cardiomyopathy: Insight into the Underlying Mechanisms.

Authors:  Dae Yun Seo; Jeong Rim Ko; Jung Eun Jang; Tae Nyun Kim; Jae Boum Youm; Hyo-Bum Kwak; Jun Hyun Bae; Amy Hyein Kim; Kyung Soo Ko; Byoung Doo Rhee; Jin Han
Journal:  Int J Mol Sci       Date:  2019-12-12       Impact factor: 5.923

Review 5.  The Urgent Need for Recommending Physical Activity for the Management of Diabetes During and Beyond COVID-19 Outbreak.

Authors:  Isabela Roque Marçal; Bianca Fernandes; Ariane Aparecida Viana; Emmanuel Gomes Ciolac
Journal:  Front Endocrinol (Lausanne)       Date:  2020-10-28       Impact factor: 5.555

6.  Association between physical activity and risk of all-cause mortality and cardiovascular disease in patients with diabetes: a meta-analysis.

Authors:  Satoru Kodama; Shiro Tanaka; Yoriko Heianza; Kazuya Fujihara; Chika Horikawa; Hitoshi Shimano; Kazumi Saito; Nobuhiro Yamada; Yasuo Ohashi; Hirohito Sone
Journal:  Diabetes Care       Date:  2013-02       Impact factor: 19.112

7.  Hyperoxia increases arterial oxygen pressure during exercise in type 2 diabetes patients: a feasibility study.

Authors:  Robert Rozenberg; Robert T Mankowski; Luc J C van Loon; Janneke G Langendonk; Eric J G Sijbrands; Anton H van den Meiracker; Henk J Stam; Stephan F E Praet
Journal:  Eur J Med Res       Date:  2016-01-08       Impact factor: 2.175

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.